- Home
- CARM vs LTBR Comparison
CARM vs LTBR Comparison
Compare CARM & LTBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CARM
- LTBR
- Stock Information
- Founded
- CARM 2016
- LTBR 1992
- Country
- CARM United States
- LTBR United States
- Employees
- CARM N/A
- LTBR N/A
- Industry
- CARM Biotechnology: Pharmaceutical Preparations
- LTBR Professional Services
- Sector
- CARM Health Care
- LTBR Consumer Discretionary
- Exchange
- CARM Nasdaq
- LTBR Nasdaq
- Market Cap
- CARM 41.5M
- LTBR 45.5M
- IPO Year
- CARM N/A
- LTBR N/A
- Fundamental
- Price
- CARM $0.94
- LTBR $7.45
- Analyst Decision
- CARM Strong Buy
- LTBR
- Analyst Count
- CARM 3
- LTBR 0
- Target Price
- CARM $12.67
- LTBR N/A
- AVG Volume (30 Days)
- CARM 183.3K
- LTBR 4.1M
- Earning Date
- CARM 11-07-2024
- LTBR 10-31-2024
- Dividend Yield
- CARM N/A
- LTBR N/A
- EPS Growth
- CARM N/A
- LTBR N/A
- EPS
- CARM N/A
- LTBR N/A
- Revenue
- CARM $20,268,000.00
- LTBR N/A
- Revenue This Year
- CARM $50.40
- LTBR N/A
- Revenue Next Year
- CARM N/A
- LTBR N/A
- P/E Ratio
- CARM N/A
- LTBR N/A
- Revenue Growth
- CARM 41.13
- LTBR N/A
- 52 Week Low
- CARM $0.80
- LTBR $2.21
- 52 Week High
- CARM $3.16
- LTBR $14.20
- Technical
- Relative Strength Index (RSI)
- CARM 40.39
- LTBR 50.91
- Support Level
- CARM $0.96
- LTBR $7.71
- Resistance Level
- CARM $1.01
- LTBR $9.40
- Average True Range (ATR)
- CARM 0.06
- LTBR 2.12
- MACD
- CARM -0.01
- LTBR -0.26
- Stochastic Oscillator
- CARM 4.74
- LTBR 18.18
About CARM Carisma Therapeutics Inc.
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.
About LTBR Lightbridge Corporation
Lightbridge Corp is a United States-based nuclear fuel technology company. The business activity of the firm is functioned through Nuclear Fuel Technology segment. The Nuclear Fuel Technology segment develops next generation nuclear fuel technology that increases the power output of commercial reactors and reduces the cost of generating electricity. Geographically, its operations are functioned through the region of Unites States.